NCT04978987View on ClinicalTrials.gov

Identification of Disease Specific Pathways and Modifiers in Phospholamban R14del Cardiomyopathy

CompletedOBSERVATIONAL
Enrollment

103

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

May 1, 2023

Study Completion Date

May 1, 2023

Conditions
Phospholamban R14del CardiomyopathyHeart FailureCardiomyopathy, Familial
Trial Locations (1)

9700 RB

University Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University Medical Center Groningen

OTHER